India to United States: Cetuximab Export Trade Route

The India to United States Cetuximab corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $24.4K USD. The route is dominated by GENEX PHARMA, which alone accounts for roughly 77% of all export value, reflecting the consolidated nature of India's cetuximab manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $4.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with cetuximab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 15.0%, placing it at rank #15 among India's top cetuximab export destinations globally.

On the import side, key buyers of Indian cetuximab in United States include TO THE ORDER OF, AS PER INVOICE, TO THE CONSIGNEE- and 1 others. TO THE ORDER OF is the single largest importer with 1 shipments valued at $18.7K USD.

India's cetuximab exports to United States are driven primarily by a handful of large-scale manufacturers. GENEX PHARMA with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GENEX PHARMA, VAMA LIFECARE PRIVATE LIMITED, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $4.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptionb/n: g027dm m/d:05/23 e/d:04/27 cetuximab 100 ml (erbitux 100 ml) and harmless medicine for human consumption cetuximab 100 ml (erbitux 100 ml)batch no. 6025sg mfg.dt:nov-23,exp, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 1 shipments worth $18.7K USD — representing 77% of all cetuximab imports from India on this route.